Turun yliopistollinen keskussairaala on yksi Suomen viidestä yliopistollisesta sairaalasta. Sairaalan toiminnasta valtaosa on keskittynyt Turussa sijaitsevaan kantasairaalaan, jonka sairaaloita ovat A-sairaala, U-sairaala ja T-sairaala sekä Tyksin kirurgiseen sairaalaan.

During the past decade, Turku University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Turku University Hospital" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Turku University Hospital" in a lesser frequency.

Most popular intervention types in "Turku University Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Elranatamab" (2 trials), "Daratumumab" (1 trials), "Dexamethasone" (1 trials), "Lenalidomide" (1 trials) and "Pomalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Turku University Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Turku University Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Turku University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Turku University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".